Avantax Advisory Services Inc. increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 5.7% ...

SPDR S&P Biotech ETF Trading Up 1.3 % Shares of NYSEARCA XBI opened at $87.13 on Monday. The firm has a market cap of $5.65 billion, a PE ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF ...

The SPDR S&P Biotech ETF (XBI) made its debut on 01/31/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. The ETF industry ...

In trading on Friday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 0.7% on the day. Components of that ETF showing particular strength include shares of Alnylam Pharmaceuticals ...

The Fund seeks to replicate as closely as possible the performance of an index derived from the biotechnology segment of a U.S. total market composite index. The Fund uses a passive management ...

Assess our live XBI chart. The chart is intuitive yet powerful, customize the chart type to view candlestick patterns, area, line graph style, bar chart or Heiken Ashi. There are dozens of tools ...

Fintel reports that on March 21, 2025, Cantor Fitzgerald initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a ...

Although LFSC launched just five months ago, the team at Emerald Advisers is highly experienced. Read why I don't recommend ...

Shares in financial firm Stifel (SF) dropped 3% today after it was told to cough up $132.5 million in damages to a U.S.